Rifadin
- Product NDC
- 0068-0660
- 11-digit product format
- 000680660
- Labeler code
- 0068
- Product ID
- 0068-0660_5cebbeae-b984-4e38-a050-896320bf049c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifampicin
- Dosage form
- KIT
- Labeler
- Sanofi-Aventis U.S. LLC
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start
- 2026-08-03
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rifadin
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1b074c23-dd35-43c9-820c-0e603481fdd3 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rifadin | RIFAMPICIN | Sanofi-Aventis U.S. LLC | 1b074c23-dd35-43c9-820c-0e603481fdd3 | 2026-08-25 | Warnings, Adverse reactions | 0068-0660 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0068-0660-50 | 00068066050 | 1 KIT in 1 CARTON (0068-0660-50) * 10 mL in 1 VIAL (0068-0600-01) * 10 mL in 1 AMPULE (0068-0610-10) | 1 kit | 2026-08-03 | No | No | Current |